ARCHIVES

“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers

This article is from The Cancer Letter archive.

Vol. 07 No. 16 | April 17, 1981

Download PDF Visit The Full Archive

Related Articles

Report Backs EPA Classification of PERC as Likely Human Carcinogen

February 12, 2010

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected

October 1, 1976

“Clinical research of all kinds in the IRP lacks a rigorous, centralized process for peer review.”

July 21, 1995

New Research Grant Awards

October 18, 1974

Intramural Clinical Research Could Lose “Critical Mass” – Chabner

November 11, 1994